Identification of aberrant pathways and network activities from high-throughput data

Jinlian Wang1, Yuji Zhang, Catalin Marian

  • 1Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA.

Insights

Complex diseases like cancer involve altered biological pathways, not just single genes. High-throughput assays help identify these pathway changes and their link to disease, aiding diagnosis and treatment strategies.

Area of Science:

  • Molecular biology
  • Systems biology
  • Genomics

Background:

  • Complex diseases, including cancer, arise from alterations in biological pathways and molecular networks, not solely from single gene mutations.
  • Diagnosing and treating these diseases requires identifying aberrant pathway activities and understanding their connection to disease pathology.

Purpose of the Study:

  • To review advancements in utilizing high-throughput biological assays for deciphering aberrant pathways and network activities.
  • To highlight specific examples where high-throughput data have elucidated disease-pathway relationships.

Main Methods:

  • Review of recent scientific literature on high-throughput biological assays.
  • Analysis of case studies demonstrating the application of high-throughput data in disease research.

Main Results:

  • High-throughput assays are effective tools for identifying molecular network and pathway aberrations.
  • Successful identification of relationships between specific diseases and altered biological pathways has been achieved using this data.

Conclusions:

  • Significant progress has been made in understanding disease mechanisms through pathway analysis.
  • Further research is needed to overcome existing challenges in the field and fully leverage high-throughput data for clinical applications.